Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Economic evaluation for hepatitis C.

R Grieve1, J Roberts

  • 1Health Services Research Unit, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, United Kingdom. richard.grieve@lshtm.ac.uk

Acta Gastro-Enterologica Belgica
|August 1, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Republicans subtly reform US medicine.

BMJ (Clinical research ed.)·1995
Same author

Age-related changes in cardiac norepinephrine release: role of calcium movement.

The journals of gerontology. Series A, Biological sciences and medical sciences·1995
Same author

US proposes radical reform of Medicare.

BMJ (Clinical research ed.)·1995
Same author

US warns against early discharge of babies.

BMJ (Clinical research ed.)·1995
Same author

Medicare plans outrage elderly people and doctors.

BMJ (Clinical research ed.)·1995
Same author

US apologises for radiation tests on unaware patients.

BMJ (Clinical research ed.)·1995
Same journal

A rare twist in the abdomen: diagnostic and therapeutic approaches to omental infarction - a case report and literature review.

Acta gastro-enterologica Belgica·2026
Same journal

GLP-1 receptor agonist-associated eosinophilic duodenitis presenting as a bowel obstruction : a case report and literature review.

Acta gastro-enterologica Belgica·2026
Same journal

Ampullary Actinomycosis Mimicking Malignancy: A Case Report and Literature Review.

Acta gastro-enterologica Belgica·2026
Same journal

Recurrent gastrointestinal bleeding after Peptide Receptor Radionuclide Therapy for a small intestine neuroendocrine tumor.

Acta gastro-enterologica Belgica·2026
Same journal

A little known cause of ischemic colitis.

Acta gastro-enterologica Belgica·2026
Same journal

Linaclotide for irritable bowel syndrome with constipation: integrating realworld evidence into the therapeutic puzzle.

Acta gastro-enterologica Belgica·2026
See all related articles

Combination therapy (CMB) for mild Hepatitis C (HCV) shows potential cost-effectiveness, reducing deaths and increasing life years. Economic evaluations are crucial for prioritizing interventions in HCV and other diseases.

Area of Science:

  • Health Economics
  • Hepatology
  • Public Health

Background:

  • Assessing the long-term cost-effectiveness of new Hepatitis C (HCV) interventions requires lifetime patient impact analysis.
  • Economic evaluations face challenges in quantifying the value of novel HCV treatments.

Observation:

  • A model estimated the cost-effectiveness of combination therapy (CMB) for mild HCV.
  • For 1000 mild HCV cases, CMB yielded 55 fewer deaths and 1.2 life year gain versus no treatment.
  • CMB incurred an additional 14,882 EURO cost, with a cost-effectiveness ratio of 8,490 EURO per Quality Adjusted Life Year (QALY).

Findings:

  • Preliminary results suggest CMB is relatively cost-effective for mild HCV.
  • Sensitivity analysis indicated cost-effectiveness is influenced by CMB effectiveness and disease progression rates.

Related Experiment Videos

  • Ongoing UK study data will refine model projections for HCV treatment.

    • Implications:

    • Economic evaluations guide resource allocation for HCV interventions.
    • The methodology can inform cost-effectiveness assessments in other disease areas.
    • Improved data will enhance the reliability of economic models for HCV treatment decisions.